Literature DB >> 30420159

Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability.

Markus Cornberg1, Frank Tacke2, Tom H Karlsen3.   

Abstract

Mesh：

Year:  2018        PMID： 30420159     DOI： 10.1016/j.jhep.2018.10.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

1.  Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals.

Authors:  Saima Mushtaq; Asraf Hussain Hashmi; Amjad Khan; Syed Muhammad Asad Raza Kazmi; Sobia Manzoor
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

2.  Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.

Authors:  Miguel Angel Martinez; Sandra Franco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Outcome of TACE treatment in HIV infected patients with hepatocellular carcinoma.

Authors:  Lingxiang Kong; Guo Wei; Tao Lv; Li Jiang; Jian Yang; Yong Zhao; Jiayin Yang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 4.  The Link between Gut Microbiota and Hepatic Encephalopathy.

Authors:  Sung-Min Won; Ki Kwang Oh; Haripriya Gupta; Raja Ganesan; Satya Priya Sharma; Jin-Ju Jeong; Sang Jun Yoon; Min Kyo Jeong; Byeong Hyun Min; Ji Ye Hyun; Hee Jin Park; Jung A Eom; Su Been Lee; Min Gi Cha; Goo Hyun Kwon; Mi Ran Choi; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

5.  A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study.

Authors:  Yong Zhao; Ling Xiang Kong; Feng Shi Feng; Jiayin Yang; Guo Wei
Journal:  BMC Cancer       Date:  2022-03-23       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.